scholarly article | Q13442814 |
P50 | author | Lawrence Richer | Q44810103 |
P2093 | author name string | Werner J Becker | |
Tamara Pringsheim | |||
Gordon Mackie | |||
Suzanne N Christie | |||
Michel Aubé | |||
Jonathan Gladstone | |||
Irene Worthington | |||
Canadian Headache Society Prophylactic Guidelines Development Group | |||
W Jeptha Davenport | |||
P433 | issue | 2 Suppl 2 | |
P921 | main subject | headache | Q86 |
migraine | Q133823 | ||
P304 | page(s) | S1-59 | |
P577 | publication date | 2012-03-01 | |
P1433 | published in | Canadian Journal of Neurological Sciences | Q5030246 |
P1476 | title | Canadian Headache Society guideline for migraine prophylaxis | |
P478 | volume | 39 |
Q38050981 | A possible role for mitochondrial dysfunction in migraine |
Q87386123 | ACE and ARB Agents in the Prophylactic Therapy of Migraine-How Effective Are They? |
Q57492131 | Age-Dependent Anti-migraine Effects of Valproic Acid and Topiramate in Rats |
Q47613993 | Amitriptyline and Sexual Function: A Systematic Review Updated for Sexual Health Practice |
Q89447972 | Auricular acupuncture for migraine: A systematic review protocol |
Q64253546 | CGRP monoclonal antibody for preventive treatment of chronic migraine: An update of meta-analysis |
Q38254097 | Current and investigational drugs for the prevention of migraine in adults and children |
Q36387731 | Dietary and Lifestyle Changes in the Treatment of a 23-Year-Old Female Patient With Migraine |
Q90084512 | Efficacy of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in the Preventative Treatment of Episodic Migraine in Adults |
Q93197713 | Factors Affecting Preventive Treatment Outcomes for Patients With Newly Diagnosed Chronic Migraine and Their Compliance With Treatment Recommendations in Chongqing Province, China: An Open-Label Prospective Study With Retrospective Baseline |
Q38658278 | Factors Associated with Favorable Outcome of Topiramate Migraine Prophylaxis in Pediatric Patients. |
Q92535802 | Flunarizine Induced Parkinsonism in Migraine Group: A Nationwide Population-Based Study |
Q24201830 | Gabapentin or pregabalin for the prophylaxis of episodic migraine in adults |
Q34303798 | How transparent are migraine clinical trials? Repository of Registered Migraine Trials (RReMiT). |
Q28647495 | Interventions for migraine prophylaxis: protocol of an umbrella systematic review and network meta-analysis |
Q36832984 | Magnesium in disease prevention and overall health |
Q36927873 | Management of headache and associated factors among undergraduate medicine and health science students of University of Gondar, North West Ethiopia |
Q38784408 | Managing Migraine During Pregnancy and Lactation |
Q90659710 | Manual acupuncture versus sham acupuncture and usual care for prophylaxis of episodic migraine without aura: multicentre, randomised clinical trial |
Q30245474 | Medication-overuse headache: risk factors, pathophysiology and management |
Q92874875 | Mutual Enhancement of Opioid and Adrenergic Receptors by Combinations of Opioids and Adrenergic Ligands Is Reflected in Molecular Complementarity of Ligands: Drug Development Possibilities |
Q37410902 | New advances in prevention of migraine. Review of current practice and recent advances |
Q35938798 | Nutraceuticals in Acute and Prophylactic Treatment of Migraine |
Q89685739 | Outcome measures for assessing the effectiveness of non-pharmacological interventions in frequent episodic or chronic migraine: a Delphi study |
Q39239760 | Pharmacokinetic Variability of Drugs Used for Prophylactic Treatment of Migraine |
Q43063871 | Pharmacological treatment of migraine during pregnancy and breastfeeding |
Q36267944 | Preventive Migraine Treatment |
Q36873484 | Preventive treatment in migraine and the new US guidelines |
Q26743537 | Recent advances in migraine therapy |
Q90730011 | Refining the Benefit/Risk Profile of Anti-Epileptic Drugs in Headache Disorders |
Q48761835 | Riboflavin and migraine: the bridge over troubled mitochondria |
Q48969987 | Riboflavin in cyclic vomiting syndrome: efficacy in three children |
Q24186656 | Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults |
Q34658774 | Studies on the pathophysiology and genetic basis of migraine. |
Q88271261 | The Evidence for the Role of Nutraceuticals in the Management of Pediatric Migraine: a Review |
Q43131557 | The Importance of Magnesium in Clinical Healthcare. |
Q91589079 | The effect of aerobic exercise on the number of migraine days, duration and pain intensity in migraine: a systematic literature review and meta-analysis |
Q58605238 | The management of common recurrent headaches by chiropractors: a descriptive analysis of a nationally representative survey |
Q43242978 | The subtle central effect of nutraceuticals: Is it placebo or nocebo? |
Q47136993 | The treatment of migraine patients within chiropractic: analysis of a nationally representative survey of 1869 chiropractors. |
Q40994128 | Topiramate for pediatric migraine prevention |
Q92626644 | Treatment patterns in patients using triptan and prophylactic medication: an analysis of clinical practice prior to the introduction of CGRP antagonists |
Q97520894 | Update of Individualized Treatment Strategies for Postural Orthostatic Tachycardia Syndrome in Children |
Q39394084 | Use of antimigraine medications and information needs during pregnancy and breastfeeding: a cross-sectional study among 401 Norwegian women |
Q38585393 | What Constitutes an "Adequate" Trial in Migraine Prevention? |
Q47102957 | Le topiramate en prévention de la migraine chez les enfants |
Search more.